Fundraise

Callie Care raises $500K to bring AI phone companions to older adults

What's the deal? Callie Care, a US agetech startup, has raised $500,000 in pre-seed funding from InterSystems Ventures for its phone-first AI companion for older adults.

Rather than relying on apps or new hardware, the platform reaches users through regular telephone calls — the technology they already know.

The AI initiates daily wellness check-ins and helps with tasks such as booking transport, ordering groceries and scheduling appointments. It also offers emotional support and remembers past conversations.

Why now? Nearly 29% of older adults in the US live alone, while families face rising care costs and a shortage of professional caregivers.

"There are not enough people to care for aging Americans, and no hiring scenario closes the gap," said co-founder and chief executive officer Yury Palevich. "That is the gap we built Callie Care for."

Early traction is strong. Since launching its minimum viable product in October 2025, more than 8,000 users have tried the platform, with 85% of active users requesting continued calls.

Those conversations average around 10 minutes and have generated more than 730 hours of dialogue.

What could go wrong? The platform gathers sensitive health data, sending families weekly mood reports and triggering alerts when concerning changes appear.

Handling that data — and clinical notifications to healthcare providers — raises privacy and accuracy stakes for a young company.

Its most ambitious plan carries risk too: passive voice biomarker analysis to spot early cognitive decline through speech patterns. Callie Care says research points to 70-90% sensitivity, against roughly 30% for traditional screening.

The signal: Agetech is emerging as a serious venture category as demographics shift and caregiving gaps widen.

With up to 80% of mild cognitive impairment cases undiagnosed, startups betting on early detection could reshape how the US supports its aging population — and Callie Care is positioning itself at that intersection of companionship and clinical insight.

Read more: Startup Weekly

More top stories